Shares of IOL Chemicals & Pharmaceuticals surged over 8% in morning trade on Thursday as investors rallied behind the company’s announcement of a potential stock split. IOL Chemicals & Pharmaceuticals, a prominent player in the pharma and specialty chemicals space, is renowned as the world’s largest producer of Ibuprofen, commanding a ~30% global market share. The stock opened slightly higher at ₹406 on the BSE, compared to its previous close of ₹405.35, and quickly climbed to an intraday high of ₹441. This spike comes ahead of a pivotal board meeting scheduled for Friday, December 27, where the company will deliberate on subdividing its equity shares with a face value of ₹10 each. To maintain compliance, the company has also closed its trading window for insiders, effective from December 19 to December 29. With its robust portfolio and the potential stock split, IOL is clearly signaling its intent to enhance shareholder value and expand market accessibility. Investors are already taking notice, as reflected in the stock’s bullish movement.